Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.

by Alberto Benazzo, Stefan Schwarz, Moritz Muckenhuber, Thomas Schweiger, Gabriela Muraközy, Bernhard Moser, José Matilla Sigüenza, György Lang, Shahrokh Taghavi, Walter Klepetko, Konrad Hoetzenecker, Peter Jaksch, Cristopher Lambers
Published 2019-01-01